file:///C|/Documents%20and%20Settings/user29/Desktop/Conference%20on%20Vaccine%20Research%20&%20Innovation%202010.txt
Key Speakers Guido Grandi, Senior Project Leader, Novartis Vaccines and Diagnostics Dr Bassam Hallis, General Project Manager, Centre for Emergency Preparedness and Response, Health Protection Agency Alexander von Gabain, Founder & Strategic Advisor to the Management and Supervisory Boards, Intercell Dr David Kirke, Associate Director of Regulatory Affairs, ERA Consulting Dr Barbara Guinn, Cancer Sciences Division, University of Southampton Jean Marc Balloul, New Venture Development Director, Transgene Lior Carmon, Founder & CEO, Vaxil Biotherapeutics Conference Introduction Vaccine Research & Innovation 2010 2nd – 3rd September 2010 Dear Colleague, Increasing use of novel technologies has boosted the vaccines industry worldwide. Recent technological breakthroughs in vaccine research, manufacturing and delivery, promise a bright future for the new generation of vaccines, particularly for chronic conditions such as cancer, auto-immune diseases and nicotine addiction. According to recent report, The Global Vaccines Market, 2008-2023, therapeutic vaccines will significantly expand the vaccines market contributing to rapid revenue growth during the period 2008 to 2023. The cancer vaccine market, led by cervical cancer vaccines, is presently one of the most lucrative areas for vaccine manufacturers. Advances are also being made in almost all adjunct areas of vaccine research, such as the mode of delivery, use of combination vaccines, vaccine adjuvant, and vaccine manufacturing. Our Vaccine Research & Innovation conference is designed to implement successful strategies and innovative technologies to develop more effective vaccines. Gain insights through industry led case studies and discussions with key decision markers from the vaccines sector. Network and collaborate with global professionals to keep up-to-date with future trends and exploring business opportunities at the two-day event. By attending this conference you will gain insights on: • Overcoming challenges to cancer vaccine development • Evaluating the immune response to combination vaccines • Accelerating new vaccine introduction in the developing world • Monitoring High sensitivity T cell immune mechanism of novel vaccines, gene therapy, protein based drugs • Assessing the key immunological observations on clinical development of pandemic influenza A (H1N1) vaccines • Examining the safety challenges on new vaccine introduction • Implementing strategies for manufacturing and purification of conjugate vaccines file:///C|/Documents%20and%20Settings/user29/Desktop...0on%20Vaccine%20Research%20&%20Innovation%202010.txt (1 of 7)7/26/2010 2:19:04 PM